TECHNOLIS
ActiveTECHNOLIS has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61k and a net result of €23k. Equity is growing by ~43.5% per year across the filed fiscal years. Its solvency ranks better than 75% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 6.43 against 21.17 in 2024; short-term debt: 15.6% and cash: 51.3% of total assets), and 15.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
84.4%
Return on assets
31.4%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-09-2026, 42 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
42 d late
2024
59 d late
2023
104 d early
2022
132 d early
2021
5 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€61k▲ 59.2%
2024 · €38k
2021: €15k
2022: €25k
2023: €23k
2024: €38k
2021 → 2025
Total assets
€72k▲ 79.6%
2024 · €40k
2021: €22k
2022: €38k
2023: €25k
2024: €40k
2021 → 2025
Net result
€23k▲ 49.8%
2024 · €15k
2021: €12k
2022: €11k
2023: €-770
2024: €15k
2021 → 2025
Working capital
€61k▲ 59.4%
2024 · €38k
2021: €15k
2022: €24k
2023: €23k
2024: €38k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€15k-€25k▲ 67.4%€23k▼ 6.4%€38k▲ 65.3%€61k▲ 59.2%
Operating result€15k-€14k▼ 5.9%€-645€18k€33k▲ 83.1%
Net result€12k-€11k▼ 7.0%€-770€15k€23k▲ 49.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 83% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €72k
Equity
€61k▲ 59.2%
Debt
€11k▲ 492%
The debt ratio rises from 4.7% to 15.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€33k▲
2024 · €18k
Cash flow
€23k▲
2024 · €15k
Solvency
84.4%▼
2024 · 95.3%
Current ratio
6.43▼
2024 · 21.17
Quick ratio
6.43▼
2024 · 21.17
Debt / equity
0.18▲
2024 · 0.05
ROE
37.2%▼
2024 · 39.5%
ROA
31.4%▼
2024 · 37.6%
Interest coverage
109.40▲
2024 · 93.26
Debt
€11k▲
2024 · €2k
Debt ≤ 1 year
€11k▲
2024 · €2k
Income taxes
€10k▲
2024 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€40k€72k▲
Fixed assets21/28€58-
Tangible fixed assets22/27€58-
Furniture and vehicles24€58-
Current assets29/58€40k€72k▲
Amounts receivable within one year40/41€11k€11k▲
Trade receivables40€6k€9k▲
Other amounts receivable41€6k€3k▼
Current investments50/53€12k€24k▲
Cash at bank and in hand54/58€17k€37k▲
Deferred charges and accrued income490/1-€141
Equity and liabilities
Total equity and liabilities10/49€40k€72k▲
Equity10/15€38k€61k▲
Contributions10/11€4k€4k=
Profit (loss) carried forward14€34k€57k▲
Amounts payable17/49€2k€11k▲
Amounts payable within one year42/48€2k€11k▲
Trade debts44€308€616▲
Suppliers440/4€308€616▲
Taxes, remuneration and social security45€620€6k▲
Taxes450/3€620€6k▲
Other amounts payable47/48€965€5k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€210€58▼
Other operating charges640/8€1k€621▼
Gross operating margin9900€20k€34k▲
Operating profit (loss)9901€18k€33k▲
Financial income75/76B€65€216▲
Recurring financial income75€65€216▲
Financial charges65/66B€195€301▲
Recurring financial charges65€195€301▲
Profit (loss) for the period before taxes9903€18k€33k▲
Income taxes67/77€3k€10k▲
Profit (loss) for the period9904€15k€23k▲
Profit (loss) for the period to be appropriated9905€15k€23k▲
Appropriation of the result
Profit (loss) to be appropriated9906€34k€57k▲
Profit (loss) brought forward from the previous period14P€19k€34k▲
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 42 days late
2025
31-12
Financial
Highest result since 2021net €23k ▲49.8%
Operating result €33k, net result €23k, both a record.
28-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 59 days late
2024
31-12
Financial
Back to profitnet €15k
Net result €15k after one loss-making year.
18-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €-770 ▼107%
Net result drops to €-770, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 12.65
Current ratio from 2.83 to 12.65; short-term debt falls from €13k to €2k.
21-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
26-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Andenne · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Jean Tousseul 15300 AndenneGround area
2,091 m²
Building footprint
88 m²
Parcel 92410B0228/00B000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rue Jean Tousseul 1, 5300 Andenne
since 20212.317.572.597
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92410B0228/00B000 | Wallonia | 2,091 m² | 1 · 88 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KNOWLEDGE INVESTOR GROUP
BE 1002.582.892
Ganshoren · Eq €61k
AMLB
BE 1004.910.003
Zedelgem · Eq €59k
MRI SOLUTION
BE 1001.475.609
Sint-Jans-Molenbeek · Eq €58k
Impact Omics
BE 0779.683.030
Tongeren-Borgloon · Eq €58k
Phytocontrol Analytics Belgium
BE 0678.407.211
Brussel · Eq €64k
Of 699 companies in sector 86910 we hold annual accounts for 521. 284 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-04-2021
Fiscal year end31-12
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.